WASHINGTON, August 28, 2002 (LSN.ca) – Children of God for Life report that five big-name pharmaceuticals and the National Institutes of Health have acquired rights to use an aborted fetal cell line for the manufacture of new vaccines. Pfizer, Novartis, Schering-Plough, Glaxo SmithKline (formerly SmithKline Beecham), Aventis Pasteur and the NIH have purchased licensing agreements with Crucell to use its patented designer cell line PER C6 developed with aborted baby tissue. See the Children of God for Life site at: www.cogforlife.org
$